These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25416840)

  • 21. Spinal cord swelling in human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis: magnetic resonance indication for early anti-inflammatory treatment?
    Silva MT; Araújo A
    Arch Neurol; 2004 Jul; 61(7):1134-5. PubMed ID: 15262750
    [No Abstract]   [Full Text] [Related]  

  • 22. HTLV-1-associated myelopathy in a solid organ transplant recipient.
    Montesdeoca Andrade MJ; Correa Diaz EP; Buestán ME
    BMJ Case Rep; 2016 Jun; 2016():. PubMed ID: 27268291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Peruvian family with a high burden of HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Alvarez C; Verdonck K; Tipismana M; Gotuzzo E
    BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26392440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HTLV-I associated myelopathy (HAM): review and recent studies.
    Osame M; Arimura K; Nakagawa M; Umehara F; Usuku K; Ijichi S
    Leukemia; 1997 Apr; 11 Suppl 3():63-4. PubMed ID: 9209299
    [No Abstract]   [Full Text] [Related]  

  • 25. [Human T-cell lymphotropic virus Type I (HTLV-I) as a cause of progressive myelopathy].
    Portegies P; Goudsmit J
    Ned Tijdschr Geneeskd; 1991 Jul; 135(29):1302-6. PubMed ID: 1865933
    [No Abstract]   [Full Text] [Related]  

  • 26. Multiple spotty lesions of the spinal cord in a Chinese patient with human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis.
    Gao H; Ye X; Cai R; Xu Q; Liang L; Izumo S; Xing HQ; Kubota R
    Int J Infect Dis; 2018 Mar; 68():1-3. PubMed ID: 29292042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical symptoms and the odds of human T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: application of best-fit logistic regression equation based on host genotype, age, and provirus load.
    Nose H; Saito M; Usuku K; Sabouri AH; Matsuzaki T; Kubota R; Eiraku N; Furukawa Y; Izumo S; Arimura K; Osame M
    J Neurovirol; 2006 Jun; 12(3):171-7. PubMed ID: 16877298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal lesions and widespread involvement of white matter associated with multi-organ inflammatory disease in human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Mendes GB; Kalil RS; Rosadas C; de Freitas MR; Puccioni-Sohler M
    Int J Infect Dis; 2014 Aug; 25():1-3. PubMed ID: 24815740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of Chronic Pain and Its Impact on Quality of Life of Patients With HTLV-1-associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
    Netto EC; Brites C
    Clin J Pain; 2011 Feb; 27(2):131-5. PubMed ID: 20842011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
    Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
    Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensory neuronopathy heralding human T cell lymphotropic virus type I myelopathy.
    Martinez ARM; Casseb RF; Martins CR; Nucci A; França MC
    J Neurovirol; 2018 Jun; 24(3):369-371. PubMed ID: 29318453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human T lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP): recent perspectives.
    Ijichi S; Osame M
    Intern Med; 1995 Aug; 34(8):713-21. PubMed ID: 8563108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunopathogenesis of human T cell lymphotropic virus type I-associated myelopathy.
    Nagai M; Jacobson S
    Curr Opin Neurol; 2001 Jun; 14(3):381-6. PubMed ID: 11371764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myelopathy associated with human T cell lymphotropic virus type 1 in a white European native to England.
    Ali A; Rudge P
    BMJ; 1992 Aug; 305(6851):453. PubMed ID: 1392959
    [No Abstract]   [Full Text] [Related]  

  • 36. Syringohydromyelia or HTLV-I-associated myelopathy/tropical spastic paraparesis. A diagnostic challenge. Case report.
    Araújo Ade Q; Leite AC; De Oliveira AL; Afonso CR; Pies J
    Arq Neuropsiquiatr; 1999 Jun; 57(2A):284-7. PubMed ID: 10412531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP): still an obscure disease.
    Pillat MM; Bauer ME; de Oliveira AC; Ulrich H; Casseb J
    Cent Nerv Syst Agents Med Chem; 2011 Dec; 11(4):239-45. PubMed ID: 22300227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human T lymphotropic virus type I associated myelopathy and myasthenia gravis: a possible association?
    Fukui T; Sugita K; Ichikawa H; Negishi A; Kasai H; Tsukagoshi H
    Eur Neurol; 1994; 34(3):158-61. PubMed ID: 8033942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in a long-term prospective cohort study of initially asymptomatic individuals in Brazil.
    Romanelli LC; Caramelli P; Martins ML; Gonçalves DU; Proietti FA; Ribas JG; Araújo MG; Carneiro-Proietti AB
    AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1199-202. PubMed ID: 23617363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of proviral load measurement for monitoring of disease activity in individual patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
    Takenouchi N; Yamano Y; Usuku K; Osame M; Izumo S
    J Neurovirol; 2003 Feb; 9(1):29-35. PubMed ID: 12587066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.